The clever RoboCop reboot teaser: 6 talking points

A fake corporate website and commercial reveal compelling first glimpses of a murderous automaton and the half-man, half-machine who replaces the killer bot

Jose Padhila's new RoboCop, featuring this ED-209 robotic killing machine, hits theaters in August 2013.
(Image credit: Omnicorp.com)

In the 1987 sci-fi action film RoboCop, the boss of a mega corporation that controls Detroit's law enforcement declares: "Detroit has a cancer," and "the cancer is crime." Now, 25 years after the cult classic's titular half-man, half-machine vowed to cure that cancer, RoboCop is back. And while a rebooted RoboCop, staring The Killing's Joel Kinnaman, may not hit theaters until August 2013, Sony Pictures is already kicking its marketing campaign into gear with a website for mega corporation OmniCorp and a fake advertisement showing off its new line of crime-fighting robots. In a teaser video (watch it below), fans get a good look at the infamous ED-209 — the defensive droid that RoboCop replaced at the beginning of the 1987 film — and a shadowy glimpse at the new RoboCop (RC 2000). From the glossy new designs to the clever marketing campaign, here are six things that have critics buzzing:

1. The questionable revival of the ED-209

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us